Sophie A. Rogers et al.
bioRxiv | February 4, 2024
The serotonin 2 receptor (5HT2R) agonist psilocybin has demonstrated rapid and long-lasting efficacy across neuropsychiatric disorders characterized by cognitive inflexibility. Psilocybin may accomplish this by inducing...
← Return to the Publications page